The evolution of active targeting in cancer therapy: bridging molecular biomarkers and intelligent nanomedicine
The mini-review outlines the development of active targeting approaches, recent progress in the design of intelligent nanomedicine empowered by biomarkers, selected clinical advances, current clinical trials, and future prospects that could expedite the clinical translation of precision nanomedicine to the mainstream c...